|Videos|September 24, 2016

Departments of Health Inform Hospitals of Local Outbreaks

John D'Angelo, MD, senior vice president, executive director Emergency Medicine Services at Northwell Health, discusses how hospitals use updates from the Department of Health to remain aware of any potential outbreaks.

John D'Angelo, MD, senior vice president, executive director Emergency Medicine Services at Northwell Health, discusses how hospitals use updates from the Department of Health to remain aware of any potential outbreaks.

Interview Transcript (slightly modified for readability)

“We pay attention to the Department of Health alerts to know when anything is on the rise and when [there] is, we just inform the staff, we make sure that everyone is aware of what to look out for, we ask the right questions when we’re intaking patients to see if [it’s] a possibility [that their infection is associated with an outbreak], and if it is, we manage it.

We haven’t seen as much [cases of mosquito-borne infections] in the past year or so as we did during the West Nile [Virus] days, a couple of years ago, but these types of things can poke their head out at any time. It’s just a matter of being aware, keeping our antennas up, and also, the Department of Health is very good whenever there’s an outbreak of anything, even if it’s two or three cases of something that’s a little bit exotic or a little bit unusual. There [are] alerts that go out regularly, and then myself and my team disseminate that down to our clinical staff.”


Related to this article

The Prospective Emergence of XDR Shigella Beyond High-Risk Groups
Los Angeles has been experiencing this challenging bacteria in recent years with the potential of it becoming carbapenem-resistant in the future. Shaun Yang, PhD, D(ABMM), FIDSA, MLS(ASCP), provides commentary about his team's work in this area and the role of genomic sequencing to uncover this troublesome pathogen.
Ebola Outbreak Tops 10,000 Cases as CDC Cites Spread to Kenya, Nigeria
The CDC reports the Bundibugyo virus outbreak in the Democratic Republic of the Congo (DRC) is now the second-largest Ebola outbreak on record. As of October 28, the agency counted 10,305 total confirmed cases and 4,996 total confirmed deaths. The overall risk to the American public and travelers remains low, and no cases tied to this outbreak have been confirmed in the US.
Cefiderocol Continues to Show Activity Against Resistant Gram-Negative Infections
Shionogi data presented at IDWeek 2026 demonstrated a 76.7% clinical response with cefiderocol in carbapenem-resistant respiratory infections and high in vitro activity against resistant P aeruginosa VAP isolates. Christine Slover, PharmD, vice president, Infectious Diseases US Medical Affairs, Shionogi, offers insights on the data as well as clinical considerations for providers when weighing the antibiotic for patients.